Event Brief
Feb 18, 2026 at 11:04 AM ET
Moderna's Flu Vaccine Review by FDA Sparks Stock Surge
By The BriefBrief
Moderna's stock rises as FDA agrees to review its flu vaccine after initial refusal.
WHO: Moderna
WHAT: FDA review of flu vaccine candidate
WHEN: Feb 18, 2026 at 10:22 AM ET
WHERE: Location not specified
WHY: FDA changed its mind after concessions from Moderna
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Page 21462 of 21461
Same format. Every time.
Continue reading — sign in or create a free account with
